Prosecution Insights
Last updated: April 19, 2026
Application No. 18/019,444

PERITONEAL DIALYSIS CYCLER USING MICROPUMP

Final Rejection §102
Filed
Feb 02, 2023
Examiner
KIM, SUN U
Art Unit
1777
Tech Center
1700 — Chemical & Materials Engineering
Assignee
BAXTER HEALTHCARE SA
OA Round
2 (Final)
78%
Grant Probability
Favorable
3-4
OA Rounds
2y 11m
To Grant
90%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allow Rate
747 granted / 954 resolved
+13.3% vs TC avg
Moderate +11% lift
Without
With
+11.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
31 currently pending
Career history
985
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
47.2%
+7.2% vs TC avg
§102
21.6%
-18.4% vs TC avg
§112
17.5%
-22.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 954 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-9 and 11 are rejected under 35 U.S.C. 102(a)(1)/102(a)(2) as being anticipated by US 2006/0189923 A1 to Neftel et al. (hereinafter “Neftel”). Regarding claim 1, Neftel discloses a peritoneal dialysis ("PD") system (see figures 1-4, 6, 9-11, 15, 20; paragraphs [0101]-[0144]) comprising: a cycler (51) including a micropump actuator (shaft 52, rollers 22 and globally the driving zone 41 meant to accommodate the pumping element 1; figures 3, 10; paragraph [0123]), an inline fluid heater or batch fluid heater (28) (see paragraphs [0110] - [0117]; figures 1a, 1b, 3, 6), a pressure transducer (pressure sensor)(44)(see fig. 20; paragraph [0137]), and at least one valve actuator (34)(see fig. 10; paragraph [0123]); a disposable set (cartridge 2 and tubing; figures 1, 6; paragraph [0101]) including a micropump head sized and shaped for mating with and being cyclically driven by the micropump actuator (tubing 37, and head part of the pumping element 1, not part of the cycler 51, see figures of the cycler 51 and cartridge 2 and pumping element 1, especially figure 10 where the cavity for the pumping element is centered around shaft 52), a pressure sensor (pressure sensor formed by several parts, among which the cavity 15) configured to operably communicate with the pressure transducer, at least one fluid valve portion or a portion of at least one fluid line for interfacing with the at least one valve actuator (39)(see figure 11; paragraphs [0124]-[0125]), and an inline fluid heating pathway or a batch heater container (a cavity (17) including a warmer port (19) and a patient port (16), said patient port (18) of the second hub chamber (8) being connected to said warmer port (19) via said warmer system (28) wherein the warmer port 19 is connected to a warmer 28 (not shown on FIG. 3) via a warmer tube connector 55 and a warmer exit line 30 and the patient port 16 is connected to the patient line 5 and the second hub chamber 8 contains a warmer port 38 connected to a warmer 28 (not shown on FIG. 3) via a warmer tube connector 23 and a warmer enter line 29(see paragraphs [0110]); and a control unit ("control means" see claims 5 and 6), wherein the disposable set is arranged to allow, and the control unit is programmed to operate the micropump actuator and the at least one valve actuator so that fresh and used dialysis fluid flows through the micropump head in a same direction (see paragraphs[0112]-[0114]), wherein the inline fluid heater or batch fluid heater of the cycler is positioned and arranged to heat the inline fluid heating pathway or the batch heater container of the disposable set, respectively, when the disposable set is mounted to the cycler (see paragraphs [0101]-[110]). Regarding claim 2, Neftel teaches implicitly that the micropump actuator and the micropump head are more accurate in the same direction than in a reverse direction (see paragraphs [0112], [0114]). Regarding claim 3, Neftel teaches that the micropump actuator includes a keyed driver (motor shaft 52 in fig. 10) and the micropump head includes a keyed recess sized and shaped (see a center hole in roller separator 12) for mating with the keyed driver of the micropump actuator (see figs. 10-11; paragraphs [0106], [0123]). Regarding claims 4-7, Neftel teaches pressure sensor including a fluid pressure chamber having a sealed diaphragm (13) and the cycler including a transmission fluid chamber (44) positioned and arranged to mate with the pressure chamber when the disposable set is mounted to the cycler (see figs. 3, 11, 20; paragraphs [0124]-[0125], [0137]). Regarding claims 8-9, Neftel teaches valve actuator (43, 39) including a pinch valve (see fig. 10, 12; paragraphs [0123], [0125]). Regarding claim 11, Neftel teaches that the disposable set being arranged to allow fresh and used dialysis fluid to flow through the micropump head in a same direction includes disposing both a patient line and a drain line of the disposable set, at least during a patient fill phase, downstream of the micropump head (see figs. 1a-1b; paragraphs [0102]-[0103], [0107]-[0108], [0112]). Response to Arguments Applicant's arguments filed 1/9/2026 have been fully considered but they are not persuasive. Applicants argue that Neftel fails to disclose a peritoneal dialysis system with a cartridge having a warmer port since Neftel routes dialysis fluid out of the cartridge to a separate warmer which warms dialysis fluid away from the cartridge. However, Neftel teaches that an inline fluid heating pathway or a batch heater container of the disposable set is positioned and arranged to heat the inline fluid heating pathway or the batch heater container of the disposable set, respectively, when the disposable set is mounted to the cycler since the inline fluid heating pathway or the batch heater container includes a warmer chamber (17), a warmer port (19), warmer (28), a warmer tube connector 55, a warmer exit line 30, a warmer port (38), a warmer tube connector (23) and a warmer enter line 29 (see Fig. 3; paragraphs [0110]; paragraphs [0102]-[0103] for Fig. 1A-1B for using the disposable set when mounted to the cycler). The warmer (28) is part of an inline fluid heating pathway or a batch heater container. Furthermore, warmer (28) heats the inline fluid heating pathway even if Neftel routes dialysis fluid out of the cartridge to a separate warmer. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN KIM whose telephone number is (571)272-1142. The examiner can normally be reached Maxi Flex. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, IN SUK BULLOCK can be reached at 571-272-5954. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /John Kim/Primary Examiner, Art Unit 1777 JK 1/26/26
Read full office action

Prosecution Timeline

Feb 02, 2023
Application Filed
Oct 07, 2025
Non-Final Rejection — §102
Jan 09, 2026
Response Filed
Jan 26, 2026
Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12601733
DEVICES FOR PERITONEAL DIALYSATE ANALYSIS
2y 5m to grant Granted Apr 14, 2026
Patent 12594368
PERITONEAL DIALYSIS SYSTEM USING DISINFECTION
2y 5m to grant Granted Apr 07, 2026
Patent 12594367
A SYSTEM AND METHOD FOR PRODUCING FLUID FOR PERITONEAL DIALYSIS
2y 5m to grant Granted Apr 07, 2026
Patent 12594369
WEIGHT-BASED PERITONEAL DIALYSIS SYSTEM INCLUDING A DRAIN TROLLEY
2y 5m to grant Granted Apr 07, 2026
Patent 12589192
PORTABLE DIALYSIS SYSTEM
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
78%
Grant Probability
90%
With Interview (+11.2%)
2y 11m
Median Time to Grant
Moderate
PTA Risk
Based on 954 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month